Chinese guideline for the diagnosis and management of CADASIL(2022 edition):a protocol
Department of Neurology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College
Cerebrovascular Diseases Group,Neurology Branch,Chinese Medical Association
ZHU Yi-cheng
Abstract：In order to promote the clinical diagnosis,management and treatment of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy(CADASIL)in China,it is necessary to construct evidence-based guidelines.The"Chinese guideline for the diagnosis and management of CADASIL(2022 edition)"will be written by using the World Health Organization(WHO)Guidelines Development Manual"and"Principles for Developing/Revising Clinical Diagnosis and Treatment Guidelines in China(2022 Edition)",and follow the evidence-based guidance development process to develop and publish formal guidance.This guide plan mainly describes the background,initiation and planning of the guide,as well as a concise development method to lay the foundation for the successful release of the subsequent guide.
Keywords：CADASILDiagnostic and treatment guidelineProtocol(not in MeSH)
Publication Date：2023-11-25
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：7( 959-965 )